Helios Digital Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Galatea Biogalatea.bioAug 2024 · $25M
Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.
HealthtechMiami Lakes, US
Carlos D. Bustamante(Executive Officer, Director)Arthur Polk(Executive Officer)Alexander Ioannidis(Director)
BoardMohit Kaushal(Director)Nicholas Katsanis(Director)
Board seatWale Ayeni· per SEC Form D
Co-investorsCEI VenturesCitta CapitalF-Prime CapitalFounder CollectiveFunction VenturesLifeX Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.